Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?

Literature DB >> 34889434

Evidence-Based Minireview: Are DOACs an alternative to vitamin K antagonists for treatment of venous thromboembolism in patients with MPN?

Francesca Schieppati¹, Anna Falanga^1,2.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34889434 PMCID： PMC8791160 DOI： 10.1182/hematology.2021000318

Source DB: PubMed Journal: Hematology Am Soc Hematol Educ Program ISSN： 1520-4383

Keyword Cloud
References

× No keyword cloud information.

31 in total

1. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

Authors: Tiziano Barbui; Guido Finazzi; Alessandra Carobbio; Juergen Thiele; Francesco Passamonti; Elisa Rumi; Marco Ruggeri; Francesco Rodeghiero; Maria Luigia Randi; Irene Bertozzi; Heinz Gisslinger; Veronika Buxhofer-Ausch; Valerio De Stefano; Silvia Betti; Alessandro Rambaldi; Alessandro M Vannucchi; Ayalew Tefferi
Journal: Blood Date: 2012-10-01 Impact factor: 22.113

2. Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia.

Authors: Juan-Carlos Hernández-Boluda; Eduardo Arellano-Rodrigo; Francisco Cervantes; Alberto Alvarez-Larrán; Montse Gómez; Pere Barba; María-Isabel Mata; José-Ramón González-Porras; Francisca Ferrer-Marín; Valentín García-Gutiérrez; Elena Magro; Melania Moreno; Ana Kerguelen; Manuel Pérez-Encinas; Natàlia Estrada; Rosa Ayala; Carles Besses; Arturo Pereira
Journal: Ann Hematol Date: 2015-02-14 Impact factor: 3.673

3. Low-dose aspirin in polycythaemia vera: a pilot study. Gruppo Italiano Studio Policitemia (GISP).

Authors:
Journal: Br J Haematol Date: 1997-05 Impact factor: 6.998

4. High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation.

Authors: Kai Wille; Parvis Sadjadian; Tatjana Becker; Vera Kolatzki; Anette Horstmann; Christiane Fuchs; Martin Griesshammer
Journal: Ann Hematol Date: 2018-08-28 Impact factor: 3.673

5. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

Authors: Clive Kearon; Elie A Akl; Joseph Ornelas; Allen Blaivas; David Jimenez; Henri Bounameaux; Menno Huisman; Christopher S King; Timothy A Morris; Namita Sood; Scott M Stevens; Janine R E Vintch; Philip Wells; Scott C Woller; Lisa Moores
Journal: Chest Date: 2016-01-07 Impact factor: 9.410

6. Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms.

Authors: Anna Falanga; Marina Marchetti; Francesca Schieppati
Journal: Hamostaseologie Date: 2021-02-15 Impact factor: 1.778

7. Cardiovascular events and intensity of treatment in polycythemia vera.

Authors: Roberto Marchioli; Guido Finazzi; Giorgina Specchia; Rossella Cacciola; Riccardo Cavazzina; Daniela Cilloni; Valerio De Stefano; Elena Elli; Alessandra Iurlo; Roberto Latagliata; Francesca Lunghi; Monia Lunghi; Rosa Maria Marfisi; Pellegrino Musto; Arianna Masciulli; Caterina Musolino; Nicola Cascavilla; Giovanni Quarta; Maria Luigia Randi; Davide Rapezzi; Marco Ruggeri; Elisa Rumi; Anna Rita Scortechini; Simone Santini; Marco Scarano; Sergio Siragusa; Antonio Spadea; Alessia Tieghi; Emanuele Angelucci; Giuseppe Visani; Alessandro Maria Vannucchi; Tiziano Barbui
Journal: N Engl J Med Date: 2012-12-08 Impact factor: 91.245